Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG)

M Glabbeke; Jaap Verweij; PG Casali; J Simes; A le Cesne; P Reichardt; R Issels; IR Judson; AT van Oosterom; JY Blay

doi:10.1016/j.ejca.2006.03.029

Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG)

M Glabbeke, Jaap Verweij, PG Casali, J Simes, A le Cesne, P Reichardt, R Issels, IR Judson, AT van Oosterom, JY Blay

Research output: Contribution to journal › Article › Academic › peer-review

87 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2277-2285
Number of pages	9
Journal	European Journal of Cancer
Volume	42
Issue number	14
DOIs	https://doi.org/10.1016/j.ejca.2006.03.029
Publication status	Published - 2006
Externally published	Yes

Research programs

EMC MM-03-86-08

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2006.03.029

http://hdl.handle.net/1765/74455

Cite this

Glabbeke, M., Verweij, J., Casali, PG., Simes, J., le Cesne, A., Reichardt, P., Issels, R., Judson, IR., van Oosterom, AT., & Blay, JY. (2006). Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG). European Journal of Cancer, 42(14), 2277-2285. https://doi.org/10.1016/j.ejca.2006.03.029

Glabbeke, M ; Verweij, Jaap ; Casali, PG et al. / Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG). In: European Journal of Cancer. 2006 ; Vol. 42, No. 14. pp. 2277-2285.

@article{10bbb4fd800046e8841059cdc9b66e2a,

title = "Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG)",

author = "M Glabbeke and Jaap Verweij and PG Casali and J Simes and {le Cesne}, A and P Reichardt and R Issels and IR Judson and {van Oosterom}, AT and JY Blay",

year = "2006",

doi = "10.1016/j.ejca.2006.03.029",

language = "Undefined/Unknown",

volume = "42",

pages = "2277--2285",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

number = "14",

}

Glabbeke, M, Verweij, J, Casali, PG, Simes, J, le Cesne, A, Reichardt, P, Issels, R, Judson, IR, van Oosterom, AT & Blay, JY 2006, 'Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG)', European Journal of Cancer, vol. 42, no. 14, pp. 2277-2285. https://doi.org/10.1016/j.ejca.2006.03.029

Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG). / Glabbeke, M; Verweij, Jaap; Casali, PG et al.
In: European Journal of Cancer, Vol. 42, No. 14, 2006, p. 2277-2285.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG)

AU - Glabbeke, M

AU - Verweij, Jaap

AU - Casali, PG

AU - Simes, J

AU - le Cesne, A

AU - Reichardt, P

AU - Issels, R

AU - Judson, IR

AU - van Oosterom, AT

AU - Blay, JY

PY - 2006

Y1 - 2006

U2 - 10.1016/j.ejca.2006.03.029

DO - 10.1016/j.ejca.2006.03.029

M3 - Article

SN - 0959-8049

VL - 42

SP - 2277

EP - 2285

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 14

ER -

Glabbeke M, Verweij J, Casali PG, Simes J, le Cesne A, Reichardt P et al. Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG). European Journal of Cancer. 2006;42(14):2277-2285. doi: 10.1016/j.ejca.2006.03.029